BUZZ BOMB™ captures over 400,000 views and a spike in online revenue driven by strategic brand expansion and Ashley ...
Study represents a significant advancement in Grove’s Bionic Biologics™ platform – CHICAGO--(BUSINESS WIRE)--February 24, 2026-- Grove Biopharma, ...
The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest new stock offering in nearly three years.
Halozyme Therapeutics (HALO) has reportedly spent up to $1.3 billion in acquiring three biotech startups in recent months.
Xeris Biopharma Holdings shares are falling Friday after the company announced a patent infringement lawsuit to protect its drug, Recorlev.
ESTERO, FLORIDA / ACCESS Newswire / February 11, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
Cathy Smith and Christophe Weber joined Boston Scientific’s board on Wednesday, according to a Monday press release from the ...
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary ...
New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...
Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today ...
Therapeutic breakthroughs and innovations driving the next era of personalized medical care BOSTON, MA, UNITED STATES, ...
As a middle schooler, you may recall learning about the Fertile Crescent of the ancient world where the Tigris and Euphrates Rivers converged. As students we may not have comprehended the importance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results